Physician profile
Gary Newman
NPI 1023085990
$3,280.32
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,756 · 2020: $522 · 2021: $480 · 2022: $124 · 2023: $380 · 2024: $19.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $398.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $962.36 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $741.68 | 2019-2024 | Entyvio |
| Abbvie INC. | $397.34 | 2019-2021 | |
| Janssen Biotech, INC. | $281.80 | 2019-2021 | |
| Gilead Sciences, INC. | $262.30 | 2020-2023 | Epclusa |
| Pfizer INC. | $232.82 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $95.86 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $92.75 | 2022 | |
| Ucb, INC. | $26.38 | 2019 | |
| Dynavax Technologies Corporation | $22.15 | 2019 | |
| Daiichi Sankyo INC. | $21.18 | 2019 | |
| Lilly USA, LLC | $19.32 | 2020 | |
| Alfasigma USA, INC. | $19.04 | 2020 | |
| Dova Pharmaceuticals | $18.44 | 2019 | |
| Merck Sharp & Dohme LLC | $18.37 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $15.79 | 2019 | |
| Nestle Healthcare Nutrition INC. | $13.89 | 2020 | |
| Braintree Laboratories, INC. | $13.69 | 2019 | |
| Endo Pharmaceuticals INC. | $13.61 | 2019 | |
| Intercept Pharmaceuticals, INC. | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.